139 related articles for article (PubMed ID: 10524594)
1. Immune mediated 'HAART' attack during treatment for tuberculosis. Highly active antiretroviral therapy.
Kunimoto DY; Chui L; Nobert E; Houston S
Int J Tuberc Lung Dis; 1999 Oct; 3(10):944-7. PubMed ID: 10524594
[TBL] [Abstract][Full Text] [Related]
2. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
3. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis.
Swaminathan S; Padmapriyadarsini C; Narendran G; Thomas BE; Anand S; Rajyalakshmi A
Indian J Chest Dis Allied Sci; 2005; 47(4):299-304. PubMed ID: 16255403
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcaemia complicating immune reconstitution in an HIV-infected patient with disseminated tuberculosis.
Ferrand RA; Elgalib A; Newsholme W; Childerhouse A; Edwards SG; Miller RF
Int J STD AIDS; 2006 May; 17(5):349-50. PubMed ID: 16643687
[TBL] [Abstract][Full Text] [Related]
5. Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART.
Zanoni BC; Phungula T; Zanoni HM; France H; Feeney ME
AIDS; 2011 Jan; 25(1):49-55. PubMed ID: 20935555
[TBL] [Abstract][Full Text] [Related]
6. Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.
Breen RA; Miller RF; Gorsuch T; Smith CJ; Ainsworth J; Ballinger J; Swaden L; Cropley I; Johnson MA; Lipman MC
J Infect Dis; 2006 May; 193(10):1437-40. PubMed ID: 16619192
[TBL] [Abstract][Full Text] [Related]
7. A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy.
Vallabhaneni S; Kumarasamy N; Wing EJ; Flanigan TP
AIDS Read; 2005 Feb; 15(2):72-5. PubMed ID: 15712396
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.
Breen RA; Smith CJ; Bettinson H; Dart S; Bannister B; Johnson MA; Lipman MC
Thorax; 2004 Aug; 59(8):704-7. PubMed ID: 15282393
[TBL] [Abstract][Full Text] [Related]
9. Progressive symptoms and signs following institution of highly active antiretroviral therapy and subsequent antituberculosis therapy: immune reconstitution syndrome or infection?
Miller RF; Shahmanesh M; Talbot MD; Wiselka MJ; Shaw PJ; Bacon C; Robertson CM
Sex Transm Infect; 2006 Apr; 82(2):111-6. PubMed ID: 16581733
[TBL] [Abstract][Full Text] [Related]
10. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G
HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents.
Cinti SK; Kaul DR; Sax PE; Crane LR; Kazanjian PH
Clin Infect Dis; 2000 Mar; 30(3):511-4. PubMed ID: 10722436
[TBL] [Abstract][Full Text] [Related]
12. Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment.
Bottieau E; Noë A; Florence E; Colebunders R
Infection; 2003 Mar; 31(2):118-20. PubMed ID: 12682819
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis.
Chilton D; Edwards SG; Pellegrino P; Miller RF
Thorax; 2008 Oct; 63(10):935-6. PubMed ID: 18820121
[No Abstract] [Full Text] [Related]
14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
15. First UK report of successful treatment of Mycobacterium simiae and immune reconstitution inflammatory syndrome in an HIV-seropositive patient.
Phillips DR; Krishnan H; Watson J
Sex Transm Infect; 2008 Aug; 84(4):271-2. PubMed ID: 18647877
[TBL] [Abstract][Full Text] [Related]
16. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
17. HIV and tuberculosis--a "cursed duo" in the HAART era.
Londhey VA
J Assoc Physicians India; 2009 Oct; 57():681-2. PubMed ID: 20329423
[No Abstract] [Full Text] [Related]
18. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterial diseases and HIV.
Pozniak A
J HIV Ther; 2002 Feb; 7(1):13-6. PubMed ID: 11956499
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic infections shortly after beginning highly active antiretroviral therapy.
Rodríguez-Rosado R; Soriano V; Dona C; González-Lahoz J
Antivir Ther; 1998; 3(4):229-31. PubMed ID: 10682143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
